TICAGRELOR PLUS ASPIRIN VS CLOPIDOGREL PLUS ASPIRIN IN MILD NON-CARDIOEMBOLIC ISCHEMIC STROKE: A RANDOMIZED, CONTROLLED, ACTIVE COMPARATOR ARM, OUTCOME ASSESSOR BLIND, FEASIBILITY STUDY

被引：0
|
作者：
Razavi, A. Sharifi [1 ]
Ahmadi, A. Moghadam [2 ]
Tabrizi, N. [1 ]
Daz, R. [1 ]
机构：
[1] Mazandaran Univ Med Sci, Neurol, Sari, Iran
[2] Thomas Jefferson Univ, Philadelphia, PA USA
来源：
INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
SO205
引用
收藏
页码：143 / 143
页数：1
相关论文
共 19 条
  • [1] Ticagrelor plus aspirin vs clopidogrel plus aspirin in mild non-cardioembolic ischemic stroke: A protocol of a randomized, controlled, active comparator arm, outcome assessor blind, feasibility study
    Sharifi-Razavi, Athena
    Ahmadi, Amir Moghadam
    Tabrizi, Nasim
    Daz, Razieh
    NEUROLOGY ASIA, 2023, 28 (03) : 535 - 540
  • [2] Acute Aspirin Plus Cilostazol Dual Therapy for Non-cardioembolic Stroke Study (ADS)
    Aoki, Junya
    Kimura, Kazumi
    Abe, Koji
    Uno, Masaaki
    Okada, Yasushi
    Urabe, Takao
    Fujimoto, Shigeru
    Matsuoka, Hideki
    Yamagata, Sen
    Yamagami, Hiroshi
    Yamamoto, Yasumasa
    Yonehara, Toshiro
    Inoue, Takeshi
    STROKE, 2018, 49
  • [3] Study protocol for aspirin plus rivaroxaban efficacy and safety in embolic stroke of undetermined source: A randomized, placebo controlled, outcome assessor blind, feasibility study
    Sharifi-Razavi, Athena
    Ghazaeian, Monireh
    Ramezanpour, Fatemeh
    NEUROLOGY ASIA, 2022, 27 (02) : 255 - 259
  • [4] PRELIMINATORY RESULT OF ASPIRIN PLUS RIVAROXABAN EFFICACY AND SAFETY IN EMBOLIC STROKE OF UNDETERMINED SOURCE: A RANDOMIZED, PLACEBO CONTROLLED, OUTCOME ASSESSOR BLIND, FEASIBILITY STUDY
    Sharifi-Razavi, A.
    Ghazaeian, M.
    Ramezanpour, F.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 296 - 296
  • [5] ASPIRIN PLUS RIVAROXABAN EFFICACY AND SAFETY IN EMBOLIC STROKE OF UNDETERMINED SOURCE: A RANDOMIZED, PLACEBO-CONTROLLED, OUTCOME ASSESSOR-BLIND, FEASIBILITY STUDY
    Razavi, A. Sharifi
    Ghazaeian, M.
    Ramezanpour, F.
    Zarvani, A.
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (02) : 85 - 85
  • [6] Aspirin plus rivaroxaban efficacy and safety in embolic stroke of undetermined source: A randomized, placebo-controlled, outcome assessor-blind, feasibility study
    Ghazaeian, Monireh
    Ramzanpour, Fatemeh
    Sharifi-Razavi, Athena
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2025, 250
  • [7] EFFICACY OF TICAGRELOR PLUS ASPIRIN IN MINOR NON-CARDIOEBOLIC ISCHEMIC STROKE (TACAMINIS): A PROTOCOL OF A RANDOMIZED CONTROLLED TRIAL
    Sharifi-Razavi, A.
    Moghadam-Ahmadi, A.
    Tabrizi, N.
    Daz, R.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 130 - 131
  • [8] Efficacy and safety of aspirin plus clopidogrel versus aspirin alone in ischemic stroke or high-risk transient ischemic attack: A meta-analysis of randomized controlled trials
    Ahmed, Mushood
    Ahsan, Areeba
    Fatima, Laveeza
    Basit, Jawad
    Nashwan, Abdulqadir J.
    Ali, Shafaqat
    Hamza, Mohammad
    Karalis, Iosif
    Ahmed, Raheel
    Alareed, Ahmad
    Ijioma, Nkechinyere N.
    Alraies, M. Chadi
    VASCULAR MEDICINE, 2024, 29 (05) : 517 - 525
  • [9] Evaluation of Selenium Supplementation in Acute Ischemic Stroke Outcome: An Outcome Assessor Blind, Randomized, Placebo-Controlled, Feasibility Study
    Sharifi-Razavi, Athena
    Karimi, Narges
    Jafarpour, Hamed
    NEUROLOGY INDIA, 2022, 70 (01) : 87 - 93
  • [10] Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
    Ying Chen
    Yan Liu
    Jingjing Zhang
    Kehua Zhou
    Xuecheng Zhang
    Hengheng Dai
    Baolin Yang
    Hongcai Shang
    Trials, 23
12